M. Marzocco
University of Florence
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by M. Marzocco.
The Journal of Urology | 1998
Giulio Nicita; Donata Villari; M. Marzocco; Vincenzo Li Marzi; Trippitelli A; Gennaro Santoro
PURPOSE We report our experience with endoluminal stent placement after percutaneous transluminal angioplasty for the treatment of post-transplant renal artery stenosis. MATERIALS AND METHODS From October 1992 to September 1996, 8 stents were successfully implanted in 7 patients affected by resistant transplant renal artery stenosis. All transplanted kidneys were procured from cadaver donors. The patients were routinely evaluated with duplex sonography and the median interval between transplantation and stenosis detection was 7.4 months (range 0.5 to 17). When serious renal stenosis was diagnosed (greater than 50%), selected angiography and percutaneous transluminal angioplasty were performed. In 8 cases (7 patients) an endoluminal metallic Palmaz stent was placed in the site of the restenosis. One patient received 2 stents repeatedly positioned in different stenosis sites. RESULTS No major complications occurred. Clinical outcome was positive in 5 patients (71.4%) and Stenosis recurred in 2 (28.5%) (less than 50% and less than 35%, respectively). Median followup after stent placement was 14.8 months (range 1 to 37). CONCLUSIONS Percutaneous endoluminal stent procedures after resistant transplant renal artery stenosis or for ex novo treatment for severe anastomotic stenoses appears to be promising. Longer followup periods are necessary for true evaluation of this procedure.
Urologia Internationalis | 2005
Giulio Nicita; V. Li Marzi; M.T. Filocamo; E. Dattolo; M. Marzocco; M.C. Paoletti; Donata Villari
Objective: The study presents an original uterus sparing technique for transvaginal repair of total genitourinary prolapse. The technique employs a synthetic mesh of mixed polypropylene and 910 polyglactin fibers. Methods: The prosthesis creates a support for the cystocele, the cervix and the enterocele. It has four anchoring sites: two at the rear in the sacrospinous ligaments and two at the front in the arcus tendineous of the levator ani muscle. Between February 2001 and December 2004, 24 patients (mean age 66.9 years), presenting symptoms of uterine prolapse, cystocele and enterocele (POP-Q stage III-IV Aa associated to II-III-IV C), were treated with our procedure. Pre- and postoperative parameters were evaluated statistically. Results: No patient had any serious complications. The mean follow-up was 31.1 months (range 6–52). 19 patients (79.1%) have shown excellent results and have been completely cured. In 5 other cases (20.8%), the cystocele was completely cured and there was a significant improvement in the hysterocele and the enterocele. One patient required surgical treatment for postoperative stress incontinence. Statistical analysis of data regarding the pre- and postoperative prolapse stage demonstrated a high degree of objective cure rates (p < 0.0001). Conclusions: While hysterectomy remains the habitual treatment for severe uterine prolapse, our technique provides a promising alternative solution. It is also significant that there were no complications of erosion or infection associated with the prosthesis.
BioMed Research International | 2018
Vincenzo Li Marzi; R. Campi; F. Sessa; A. Pili; G. Vignolini; Mauro Gacci; M. Marzocco; E. Dattolo; Enrico Minetti; Mariella Santini; Massimo Gatti; Adriano Peris; Sergio Serni
Transplant renal artery stenosis (TRAS) is the most frequent vascular complication after kidney transplantation (KT) and has been associated with potentially reversible refractory hypertension, graft dysfunction, and reduced patient survival. The aim of the study is to describe the outcomes of a standardized Duplex Ultrasound- (DU-) based screening protocol for early diagnosis of TRAS and for selection of patients potentially requiring endovascular intervention. We retrospectively reviewed our prospectively collected database of KT from January 1998 to select patients diagnosed with TRAS. The follow-up protocol was based on a risk-adapted, dynamic subdivision of eligible KT patients in different risk categories (RC) with different protocol strategies (PS). Of 598 patients included in the study, 52 (9%) patients had hemodynamically significant TRAS and underwent percutaneous angioplasty (PTA) and stent placement. Technical and clinical success rates were 97% and 90%, respectively. 7 cases of restenosis were recorded at follow-up and treated with re-PTA plus stenting. Both DU imaging and clinical parameters improved after stent placement. Prospective high-quality studies are needed to test the efficacy and safety of our protocol in larger series. Accurate trial design and standardized reporting of patient outcomes will be key to address the current clinical needs.
European Urology | 2005
Maria Teresa Filocamo; Vincenzo Li Marzi; Giulio Del Popolo; Filippo Cecconi; M. Marzocco; Aldo Tosto; Giulio Nicita
European Urology | 2007
Maria Teresa Filocamo; Vincenzo Li Marzi; Giulio Del Popolo; Filippo Cecconi; Donata Villari; M. Marzocco; Giulio Nicita
Transplantation Proceedings | 2005
V. Li Marzi; M.T. Filocamo; E. Dattolo; M. Zanazzi; M.C. Paoletti; M. Marzocco; Donata Villari; Maurizio Salvadori; Giulio Nicita
Transplantation Proceedings | 2007
M.T. Filocamo; M. Zanazzi; V. Li Marzi; M. Marzocco; L. Guidoni; E. Dattolo; Giulio Nicita
European Urology | 2017
Giulio Nicita; Donata Villari; Simone Caroassai Grisanti; M. Marzocco; Vincenzo Li Marzi; Alberto Martini
The Journal of Urology | 2013
Giulio Nicita; Vincenzo Li Marzi; Marco Mencarini; A. Cocci; Donata Villari; M. Marzocco
European Urology Supplements | 2006
G. Del Popolo; M.T. Filocamo; V. Li Marzi; M. Marzocco; E. Dattolo; Aldo Tosto; Donata Villari; Giulio Nicita